Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

366
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
366
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

4.3K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.3K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.4K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.7K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.7K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

339
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
339
Standard Precaution01:26

Standard Precaution

2.5K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strategy to Reduce >350 000 Yearly Deaths From Atherosclerotic Coronary Artery Disease by 2050 in the United States.

Circulation. Population health and outcomes·2026
Same author

Generation and characterization of two human induced pluripotent stem cell lines from young and older male donors.

Stem cell research·2025
Same author

Variability in State-Level Regulations Regarding Occupational Radiation Exposure.

Journal of the Society for Cardiovascular Angiography & Interventions·2025
Same author

Effect of Frailty on In-Hospital Mortality and Complications of PCI: An NCDR Registry Report.

Journal of the American College of Cardiology·2025
Same author

Challenges in diagnosing coronary microvascular dysfunction and coronary vasospasm.

Cardiovascular revascularization medicine : including molecular interventions·2025
Same author

The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma.

Lancet (London, England)·2025
Same journal

Post-market safety profile of the CardioMEMS HF System: A MAUDE disproportionality and network analysis.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same journal

Editorial: That's why it's called "hardening of the arteries". The challenge of PCI in calcified coronary arteries.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same journal

Incidence and prognostic value of electrocardiographic changes in patients with myocardial injury after elective PCI.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same journal

Eyeballing versus comprehensive geriatric frailty assessment and outcomes after transcatheter aortic valve replacement: Insights from a large cohort.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same journal

An assessment of the accuracy of a novel peripheral artery disease scoring system to identify obstructive coronary artery disease in patients with severe aortic stenosis.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same journal

Lipoprotein(a) testing in invasive coronary angiography: Screening yield and anatomic coronary disease burden.

Cardiovascular revascularization medicine : including molecular interventions·2026
See all related articles

Related Experiment Video

Updated: Nov 26, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.6K

Lessons Learned From the MERS-CoV Outbreak

Nadia R Sutton1, Kris R Kawamoto1

  • 1Division of Cardiovascular Medicine, Michigan Medicine, Ann Arbor, MI, United States of America.

Cardiovascular Revascularization Medicine : Including Molecular Interventions
|December 11, 2020
PubMed
Summary

No abstract available in PubMed .

Keywords:
Acute coronary syndromeCOVID-19MERS-CoV

More Related Videos

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.4K
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

59.5K

Related Experiment Videos

Last Updated: Nov 26, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.6K
Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.4K
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

59.5K